A Buprenorphine Program Evaluation Before and During the COVID-19 Pandemic.
J Nurse Pract
; 18(3): 267-271, 2022 Mar.
Article
em En
| MEDLINE
| ID: mdl-35013677
ABSTRACT
This project evaluated the service delivery (ie, attendance rate) of a buprenorphine management treatment program and compared patient recovery-related information between service methods. This was a medical record review and cross-sectional comparison of pre-COVID-19 vs post onset of COVID-19 data. In the sample of 28 adults, mean attendance rates did not differ significantly before (99.46%) vs during the pandemic (96.13%; t = 1.92, P = .07). Patient participation in therapy before and during the pandemic did differ significantly (χ2 = 1.98, P = .03). The use of telemental health services within a BMT program may be a viable option when normal in-person services are disrupted.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Evaluation_studies
Idioma:
En
Revista:
J Nurse Pract
Ano de publicação:
2022
Tipo de documento:
Article